About

I currently lead a team developing virtual cells, AI models that predict and explain how cells respond to chemical and genetic perturbations, with the goal of accelerating the discovery of new therapies. Previously, at Valence, I built the company's molecular design and AI platform, spanning generative drug design, property prediction, and multi-objective optimization. I also led the development of one of the earliest agentic AI systems for drug discovery.

I completed my PhD in Computational Biology at Université de Montréal, where I studied genome evolution. I also teach AI courses for medical professionals at McGill University and Université d'Abomey-Calavi in Benin.

Beyond research, I invest in and help build early-stage ventures across techbio, healthcare, clean technology, and other emerging fields. I grew up in Benin and remain actively involved in supporting entrepreneurship and local investment there. More about this work can be found on the ventures page.